Discount Agreement for Bimatoprost (0.1mg/ml) with DAK-Gesundheit
Notice title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum WS Bimatoprost (ausschl. in der Wirkstärke 0,1mg/ml), ATC S01EE03 f. d. Z. 01.6.26-31.5.28 (zzgl. V.-Option 1x12 Mon)
Status
Active
Submission Deadline
913 days remaining
Contracting authority
Location
Hamburg, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-263531-2026
Source
DAK-Gesundheit is seeking partners for a non-exclusive discount agreement for Bimatoprost (0.1mg/ml) starting June 2026. Companies can join at any time under the same conditions.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 263531-2026HTML
- TED PDF — 263531-2026PDF
- TED XML — 263531-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Required
Legal Basis
32014L0024